SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001415889-22-000438
Filing Date
2022-01-06
Accepted
2022-01-06 18:40:23
Documents
2
Period of Report
2022-01-04

Document Format Files

Seq Description Document Type Size
1 form3-01062022_030115.html 3  
1 form3-01062022_030115.xml 3 1669
2 ex24-01062022_030115.htm EX-24 7892
  Complete submission text file 0001415889-22-000438.txt   10900
Mailing Address 828 WINTER STREET WALTHAM MA 02451
Business Address 828 WINTER STREET WALTHAM MA 02451 617-833-1027
Xilio Therapeutics, Inc. (Issuer) CIK: 0001840233 (see all company filings)

IRS No.: 851623397 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O AKERO THERAPEUTICS, INC. 601 GATEWAY BOULEVARD, SUITE 350 SOUTH SAN FRANCISCO CA 94080
Business Address
Xu Yuan (Reporting) CIK: 0001858214 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40925 | Film No.: 22516041